原发性肝癌介入治疗适形放射治疗及综合治疗前瞻性探究.docVIP

原发性肝癌介入治疗适形放射治疗及综合治疗前瞻性探究.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
原发性肝癌介入治疗适形放射治疗及综合治疗前瞻性探究

原发性肝癌介入治疗适形放射治疗及综合治疗前瞻性探究【摘要】 目的 比较单纯介入肝动脉化疗栓塞(TACE)、单纯适形放射治疗(3DCRT)、TACE+3DCRT对原发性肝癌(PHC)的疗效。方法 67例PHC患者随机分为3个组,A组25例(TACE1~5次,平均3.2次),B组20例(3DCRT45~60 Gy,平均50 Gy),C组22例(TACE+3DCRT,先行TACE1~4次,平均3次,休息4~8周后3DCRT;TACE和3DCRT方法与A,B组相同)。介入化疗先将氟脲嘧啶1000~1250 mg和羟基树碱20~30 mg后将顺铂60~80 mg和丝裂霉素14~20 mg(或阿霉素50~60 mg)与超液化碘油10~30 mg充分混合成乳剂缓慢注入,再用1~2 mm明胶海绵颗粒栓塞肝动脉。适形放疗采用6MV-X直线加速器治疗。结果 1、2、3年生存率A组分别为61.3%、34.0%、19.8%;B组分别为53.1%、31.3%、18.8%;C组分别为74.8%、57.0%、40.4%。C组A组和B组(Logrank检验,PABC、PAC、PBC0.05)发症主要为发热,C组A组B组(χ2检验,PA组B组(t检验和方差分析,PB组A组(χ2检验,PTACE3DCRT)和肝功能不全(TACE+3DCRT3DCRTTACE)。 【关键词】 肝肿瘤/治疗;肝肿瘤/放射疗法;栓塞,治疗性 Foresightedness research of three dimensional conformal radiotherapy and complex therapy for primary hepatic cancer LU Yuan-quan.Tumor radiotherapy department.The First people”s Hospital of Shang Qiu He nan 476100,China 【Abstract】 Objective To compare the therapeutic effects of transcatheter hepatic chemoembolization (TACE)alone、three dimensional conformal radiotherapy(3DCRT)alone,and TACE+3DCRT.Methods 67 patients with primary hepatic cacer were randomized divided into three groups:A-25patients were treated with 1-5 times of TACE alone;B-20 patients,radiotherapy with 3DCRT 45-60 Gy average 50 Gy;Group c-22 patients,TACE plus radiotherapy,at the first time were received 1-4 times of TACE by radiotherapy,then with 3DCRT after a rest of 4-8 week.for TACE,1000-1250 mg 5-fluorouracil and 20-30 mg hydroxyeamptothecine were perfused into the hepatic arteries,then 60-80 mg cisplatin and 14-20 mg mitomycin(or 50-60 mg epirubicin)and iodized oil 10-30 ml were given to embolized the hepatic arteries which was then followed by 1-2 mm gelform spieces.For 3DCRT,radiation was given by 6MV X-ray.Results The overall survivals at 1-,2-and 3-years were 61.3%,34.0%and 19.0%for A-group TACE alone,53.1%,31.3%and 18.8%for B-group 3DCRT;74.8%,57.0%and 40.4%for C-group TACE+3DCRT.The differences in the survivals are statistically significant(P216 cm?3者,靶区单次剂量为4 Gy,每周1、3、5治疗,总剂量为DT36~44 G

文档评论(0)

linsspace + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档